GS0401: Custom manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical and laboratory use
GS0441: Medical services; Medical services, namely, gene therapy services
GS0421: Development of new technology for others in the fields of genetics, therapeutics, and biotechnology, agriculture, energy, biochemistry, the chemical industry, and the environment; Research and development of environmentally friendly forms of energy and power; Development of products being genetic approaches effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize cell function or disease states; Research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use
Case File Event Statements
2/7/2024 - 10 months ago
51 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLYType:ASCK
2/7/2024 - 10 months ago
50 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLYType:ASCK
7/22/2022 - 2 years ago
49 - CANCELLED SEC. 8 (6-YR)Type:C8..
1/12/2021 - 3 years ago
48 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILEDType:REM1
6/9/2020 - 4 years ago
47 - REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATEDType:CORV